You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
Cost recovery impact statement: Blood, blood components and biologicals (human cell and tissue therapies), 1 July 2014 - 30 June 2015
Version 1.0, June 2014
5. Financial performance
Cost recovery revenue will be reported in the Department of Health's Annual Report in accordance with the Finance Minister's Orders.
The TGA executive is provided with monthly financial reports showing progress budget and an analysis of financial performance and position undertaken by the TGA Chief Financial Officer.